A new cell therapy for generalized myasthenia gravis
Part of Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This trial tests a new type of cell therapy called STAR-T cells for adults with generalized myasthenia gravis whose symptoms are not well controlled with current treatments. The goal is to stop the immune system from attacking the body's own tissues, which might reduce muscle weakness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old
- Have been diagnosed with generalized myasthenia gravis (a condition causing muscle weakness throughout the body)
- Have symptoms that are getting worse despite being on treatment for several months
- Have tried at least two different immune-suppressing treatments, like steroids or biologics
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cell therapy (CAR-T cells) for people with generalized myasthenia gravis. It aims to reduce symptoms and improve daily life by targeting and destroying faulty immune cells.
This trial tests multiple treatment combinations for people with myasthenia gravis (MG), a condition that causes muscle weakness. It aims to find safer and more effective options by comparing different therapies.
This trial tests an investigational drug called SHR-2173, given as an injection, for people with generalized myasthenia gravis. It aims to see if the drug can improve muscle strength and daily function.
This trial tests an investigational drug called IMVT-1402 to see if it improves symptoms in people with generalized myasthenia gravis (gMG). If you have mild to severe gMG and are looking for new treatment options, this study may be a fit.
This study tests a new medicine called HN2301 for people with generalized myasthenia gravis that has not improved with standard treatments. The goal is to see if it is safe and if it helps reduce symptoms.
This trial tests a new cell therapy called STAR-T, which uses your own immune cells to target and attack the faulty immune cells that cause multiple sclerosis (MS). It aims to slow or stop the disease in people who have not responded to other treatments.
Hear when a new Generalized Myasthenia Gravis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.